LABA
Olodaterol
Brand names: Striverdi Respimat
Adult dose
Dose: 5 micrograms (2 puffs) OD
Route: Inhaled
Frequency: OD
Clinical pearls
- COPD; once-daily LABA
- Not licensed for asthma monotherapy
Contraindications
- Asthma without ICS
Side effects
- Tachycardia
- Tremor
- Hypokalaemia
- Headache
- Paradoxical bronchospasm
Interactions
- β-blockers
- QT-prolonging drugs
Reference: BNF; NICE NG115; https://bnf.nice.org.uk/drugs/olodaterol/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Asthma in Adults · BTS/SIGN British Guideline on Asthma 2019; NICE NG80
- Pulmonary Embolism Assessment · NICE NG158; ESC 2019 PE Guidelines
- COPD Exacerbation Management · NICE NG115 / GOLD 2024
- Community-Acquired Pneumonia (CURB-65) · BTS 2009 / NICE NG138
- Acute Pulmonary Embolism · BTS 2003 / ESC 2019
- Pleural Effusion Assessment · BTS 2010